上海九龙男子医院

国家级联合实验室，中药乳剂工程研究中心，国家高新技术企业、农业产业化龙头企业、专精特新企业。涵盖中成药、保健食品、美妆日化、运动营养、基地农业等多角化经营。

成都普济中医药研究院中医门诊部是一所专门从事中医防治肿瘤的医疗机构，专注于中医治疗各种良恶性肿瘤。在治疗上面有着独到的方法和见解。

仟源医药

全国青少年劳动技能与智能设计大赛

【合景装饰】办公室装修设计公司,余年大品牌,专业的广东地区写字楼办公室、厂房内部装修设计施工公司.人团队,多名行业装修设计专家,服务于办公室装修,写字楼装修设计,酒店会所,综合商业空间,房产建筑,厂房办公室装修设计施工,写字楼展厅设计施工等厂房内部装饰施工的装修公司,目前在广州/东莞/深圳/佛山/惠州/珠海/中山等地建设了众多厂房办公室装修设计施工项目,合景办公室装饰设计施工公司您值得信赖.

westvacbiopharmaisfoundedbyacademicianweiyuquanfromwestchinahospitalofsichuanuniversity,togetherwithscientistsfromstatekeylaboratoryofbiotherapy(sklb).itsheadquarterislocatedintheinternationalbio-town,chengdu.theceoofwestvacbiopharmaisprof.weiyuquan,whoistheacademicianofchineseacademyofsciencesaswellasthedirectorofstatekeylaboratoryofbiotherapy.westvaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.ithasattachedgreatimportanceintheresearchanddevelopment(r&d)ofcovid-vaccineespeciallyandbuildingacovid-vaccineproductionplatform.statekeylaboratoryofbiotherapy(sklb)wasestablishedbytheministryofsciencesandtechnologyofchinainandbecameoneofthenationalr&dplatformsfornoveldrugsfoundedbytheministriesofsciencesandtechnologyaswellasthatofhealthofchinain.itisalsosupportedbynationalcollaborativeinnovationprogramandhasbecomethenationalcollaborativeinnovationcenterforbiotherapysince.westchinahospitalofsichuanuniversity，foundedin,isthenationalcenterfordiagnosisandtreatmentofsevereandcriticaldiseasesinwesternchina.itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.relyingonthemedicalresourcesofstatekeylaboratoryofbiotherapyandwestchinamedicalcenter,westvachasadoptedrecombinantproteinmethodologytodevelopthecovid-vaccine.becauseofthesafetyoftheproteinvaccine,itisalsotheonlycovid-vaccineapprovedfortheuseinchildrenoveryearsoldinchina.thevaccinewasapprovedbythenationalmedicalproductsadministrationforclinicaltrialsonaugust,.phasei/iiclinicaltrialshavebeencompleted,andphaseiiiclinicaltrialsarebeingcarriedoutinnepal,kenya,japanandothercountries.thevaccinetargetsthespikeproteinbindingdomain(s-rbd)ofsars-cov-,producingneutralizingantibodiestoblockcovid-infectionofhumancells.theresultwaspublishedonnature,theworld’sfamousscientificjournalonjulyth,.ithasalsobeenthefirstpaperofcovidvaccinepublishedbynaturesincethepandemicoutbreak.thes-rbdgeneofthecovid-virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.suchtechnologyiseasytobemass-producedandbroughttothemarket.westvacbiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.